FINWIRES · TerminalLIVE
FINWIRES

Orsted Posts Record Renewable Output in Q1

By

-- Orsted said Wednesday its renewable energy generation in Q1 reached a record high, with power generation from offshore wind farms and onshore energy assets rising 16% year over year to 11.3 terawatt-hours, driven by project ramp-ups and higher wind speeds.

Power generation from offshore wind sources was up 27% versus year-ago levels to 6.9 TWh, helped by a 10% rise in wind speeds and ramp-up at Borkum Riffgrund 3 in Germany and Greater Changhua 4 in Taiwan.

Power sales from this segment correspondingly grew to 6.3 TWh over the year from 4.8 TWh.

The offshore segment generated 21.29 billion Danish kroner ($3.35 billion) in revenue during the quarter, a 45% jump from the previous year's 14.64 billion kroner.

Meanwhile, Orsted's onshore wind and solar assets produced 4.4 TWh of power in Q1, a 3% rise from a year earlier, driven by the commissioning of Badger Wind in the US and Bahren West 1 in Germany.

The onshore segment posted a 5% increase in revenue year over year to 886 million kroner.

The company's bioenergy and other assets posted a 9% growth in heat generation to 3.5 TWh and a 6% decline in power output to 1.4 TWh.

The segment's gas sales improved by 19% to 6.3 TWh, and its power sales inched up 9% to 686 gigawatt-hours.

Correspondingly, the segment recorded a 3% rise in revenue to 5.51 billion kroner.

Orsted also said it "made significant progress on its construction projects across three continents."

In the US, it delivered the first power from the Revolution Wind project to New England and installed the first wind turbines at Sunrise Wind outside New York.

In Europe, it has begun installing foundations for Hornsea 3 in the UK and Baltica 2 in Poland.

In Taiwan, it said the offshore wind farms Greater Changhua 2b and 4 remain on track for commissioning in Q3.

The Danish state is a majority shareholder in Orsted with a 50.1% stake, and Norway's Equinor (EQNR) is the second-largest shareholder with a 10% stake.

Price: $37.52, Change: $-3.84, Percent Change: -9.28%

Related Articles

Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Revvity

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month price target from $102 to $108, based on 18.3x our 2027 EPS view. This is below the company's five-year historical forward average P/E of 21.4x. Our 2026 EPS estimate is $5.30 (down from $5.41), and our 2027 EPS estimate is $5.89 (down from $6.00). We think RVTY's commentary on pharma and biotech end markets was more positive than in previous quarters, with management citing the strongest performance in this segment since early 2023. The positive growth from academic and government customers in the U.S. for the first time since Q2 2023 also signals a potential inflection. We anticipate a near-1% sales decline in 2026 given the recently announced China immunodiagnostics business divestiture. On an organic basis, we anticipate near-3.5% growth over the full year. The adjusted EPS midpoint of $5.275 implies 4.2% annual EPS growth, though we anticipate earnings growth will accelerate by over 11% in 2027.

Australia

Rapid7, Qualys Q1 Upside Driven by AI Push But Outlooks Limit Sentiment, Morgan Stanley Says

Rapid7 (RPD) and Qualys (QLYS) delivered slight Q1 beats while increasingly focusing on artificial intelligence-driven cybersecurity products, but overall sentiment is unlikely to improve given the companies' flat to slightly weaker outlooks, Morgan Stanley said in a note Wednesday.For Q2, Rapid7 expects revenue to continue declining and annual recurring revenue is expected to fall further to around $820 million. Qualys' outlook for 2026 is stable but lacks acceleration, with unchanged billings guidance implying continued low-to-mid single-digit growth, the investment bank said.Morgan Stanley said Rapid7 management leaned heavily into the AI and cybersecurity narrative, shifting value toward proactive exposure management, managed detection and response services, AI-driven security operations center automation, and large-scale remediation, but the company will need to show these improvements in its results before it gets credit for a turnaround.Qualys management also emphasized accelerating momentum in exposure and threat management, Agent Val, TruRisk Eliminate, autonomous exploit validation, and AI-native risk operations center workflows, arguing that advanced AI models will increase vulnerability volumes and shorten exploit windows, according to the note.Morgan Stanley lowered its price target on Rapid7 to $9 from $10, while keeping its equal-weight rating. The firm also cut Qualys' price target to $96 from $117, and maintained its underweight rating.Price: $6.71, Change: $+0.03, Percent Change: +0.45%

$QLYS$RPD
Mining & Metals

TSX up 360 Points With Miners, Financials Leading Gains

The Toronto Stock Exchange is up 360 points at midday with miners (+5.2%) and financials (+15%), the best performers.Energy and info tech, down 4.8% and 1.6%, respectively, are the worst performers.Energy stocks are down as oil prices sink on hopes that the U.S. and Iran may be nearing a deal to re-open the Strait of Hormuz, media reports say.In domestic news, the Ivey Purchasing Managers Index (PMI) data released Wednesday showed that Canadian economic activity grew in April at the fastest pace in seven months as employment and prices accelerated. The seasonally adjusted index rose to 57.7 last month from 49.7 in March, its highest level since September.In stocks, Vermilion Energy (VET.TO) slumped over 12% to a fresh 52-week low, after it reported a first-quarter earnings miss.

$^GSPTSE$.GSPTSE$VET.TO